Management of early hepatocellular carcinoma: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association

Gholami, Sepideh, Perry, Lauren M, Denbo, Jason W, Chavin, Kenneth, Newell, Philippa, Ly, Quan, St Hill, Charles, Morris-Stiff, Gareth, Kessler, Jonathan, Frankel, Timothy L, Parikh, Neehar D, Philips, Prejesh, Salti, George, Augustin, Toms, Aucejo, Federico, Debroy, Meelie, Coburn, Natalie, Warner, Susanne G (May 2021) Management of early hepatocellular carcinoma: results of the Delphi consensus process of the Americas Hepato-Pancreato-Biliary Association. Hepato Pancreato Biliary, 23 (5). pp. 753-761. ISSN 1365-182X

URL: https://www.ncbi.nlm.nih.gov/pubmed/33008733
DOI: 10.1016/j.hpb.2020.09.013

Abstract

BACKGROUND: There are many potential treatment options for patients with early stage hepatocellular carcinoma (HCC) and practice patterns vary widely. This project aimed to use a Delphi conference to generate consensus regarding the management of small resectable HCC. METHODS: A base case was established with review by members of AHPBA Research Committee. The Delphi panel of experts reviewed the literature and scored clinical case statements to identify areas of agreement and disagreement. Following initial scoring, discussion was undertaken, questions were amended, and scoring was repeated. This cycle was repeated until no further likelihood of reaching consensus existed. RESULTS: The panel achieved agreement or disagreement consensus regarding 27 statements. The overarching themes included that resection, ablation, transplantation, or any locoregional therapy as a bridge to transplant were all appropriate modalities for early or recurrent HCC. For larger lesions, consensus was reached that radiofrequency ablation and microwave ablation were not appropriate treatments. CONCLUSION: Using a validated system for identifying consensus, an expert panel agreed that multiple treatment modalities are appropriate for early stage HCC. These consensus guidelines are intended to help guide physicians through treatment modalities for early HCC; however, clinical decisions should continue to be made on a patient-specific basis.

Item Type: Paper
Subjects: diseases & disorders
diseases & disorders > neoplasms
diseases & disorders > cancer > cancer types > liver cancer
CSHL Authors:
Communities: CSHL labs > Gholami Lab
SWORD Depositor: CSHL Elements
Depositing User: CSHL Elements
Date: May 2021
Date Deposited: 29 Sep 2023 20:16
Last Modified: 23 Jan 2024 21:21
Related URLs:
URI: https://repository.cshl.edu/id/eprint/41090

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving